12-63984061-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_020762.4(SRGAP1):c.182C>T(p.Thr61Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000631 in 1,554,296 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_020762.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SRGAP1 | NM_020762.4 | c.182C>T | p.Thr61Met | missense_variant | 2/22 | ENST00000355086.8 | NP_065813.1 | |
SRGAP1 | NM_001346201.2 | c.182C>T | p.Thr61Met | missense_variant | 2/22 | NP_001333130.1 | ||
SRGAP1 | XM_024449096.2 | c.182C>T | p.Thr61Met | missense_variant | 2/14 | XP_024304864.1 | ||
SRGAP1 | XM_024449097.2 | c.182C>T | p.Thr61Met | missense_variant | 2/12 | XP_024304865.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SRGAP1 | ENST00000355086.8 | c.182C>T | p.Thr61Met | missense_variant | 2/22 | 1 | NM_020762.4 | ENSP00000347198.3 |
Frequencies
GnomAD3 genomes AF: 0.0000924 AC: 14AN: 151502Hom.: 0 Cov.: 28
GnomAD3 exomes AF: 0.0000685 AC: 16AN: 233526Hom.: 0 AF XY: 0.0000630 AC XY: 8AN XY: 127052
GnomAD4 exome AF: 0.0000599 AC: 84AN: 1402682Hom.: 0 Cov.: 30 AF XY: 0.0000645 AC XY: 45AN XY: 697844
GnomAD4 genome AF: 0.0000923 AC: 14AN: 151614Hom.: 0 Cov.: 28 AF XY: 0.000108 AC XY: 8AN XY: 74042
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 04, 2024 | The c.182C>T (p.T61M) alteration is located in exon 2 (coding exon 2) of the SRGAP1 gene. This alteration results from a C to T substitution at nucleotide position 182, causing the threonine (T) at amino acid position 61 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Thyroid cancer, nonmedullary, 2 Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The SRGAP1 p.T61M variant was not identified in the literature nor was it identified in ClinVar. The variant was identified in dbSNP (ID: rs778174499) and in control databases in 19 of 264564 chromosomes at a frequency of 0.00007182, and was observed at the highest frequency in the East Asian population in 9 of 17468 chromosomes (freq: 0.0005152) (Genome Aggregation Database March 6, 2019, v2.1.1). The p.T61 residue is not highly conserved in mammals and computational analyses (MUT Assesor, PolyPhen-2, SIFT, MutationTaster, Revel, FATHMM, MetaLR, DANN) do not suggest a high likelihood of impact to the protein; however this information is not predictive enough to rule out pathogenicity. The variant occurs outside of the splicing consensus sequence and in silico or computational prediction software programs (Splice AI exome) do not predict a difference in splicing. In summary, based on the above information the clinical significance of this variant cannot be determined with certainty at this time. This variant is classified as a variant of uncertain significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at